Loading...

Artivion, Inc.

AORTNYSE
Healthcare
Medical - Devices
$30.91
$-0.66(-2.09%)

Artivion, Inc. (AORT) Stock Competitors & Peer Comparison

See (AORT) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
AORT$30.91-2.09%1.3B-60.71-$0.51N/A
ABT$126.19-1.84%219.6B15.81$7.98+1.80%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
BSX$104.92-1.72%155.2B62.44$1.68N/A
SYK$392.73-1.92%150.7B53.20$7.41+0.83%
MDT$90.24-1.53%115.6B25.00$3.61+3.10%
EW$79.31-2.28%46.5B33.18$2.39N/A
DXCM$80.77-9.31%31.7B56.87$1.42N/A
PHG$26.20-2.28%24.9B145.50$0.18+3.36%
STE$226.49-1.21%22.3B36.71$6.17+1.00%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

AORT vs ABT Comparison August 2025

AORT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AORT stands at 1.3B. In comparison, ABT has a market cap of 219.6B. Regarding current trading prices, AORT is priced at $30.91, while ABT trades at $126.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AORT currently has a P/E ratio of -60.71, whereas ABT's P/E ratio is 15.81. In terms of profitability, AORT's ROE is -0.07%, compared to ABT's ROE of +0.32%. Regarding short-term risk, AORT is less volatile compared to ABT. This indicates potentially lower risk in terms of short-term price fluctuations for AORT.Check ABT's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;